New podcast Long Read – Two-component vaccines Listen in to the latest Drug Safety Matters podcast Long Read about how to prevent medication errors with two-component vaccines.
Restoring invisible and abandoned trials – new podcast episode In the new episode of the Drug Safety Matters podcast, explore the problem of the data we don't see and find out what can be done to peel back the curtain.
New podcast long read – Patient's advocate The latest episode of the Drug Safety Matters podcast has dropped. Tune in to hear Marie Lindquist reflect on a career dedicated to patient safety.
How drug safety can help fight resistant bugs Jean Marie Vianney Habarugira and Albert Figueras are all for using pharmacovigilance databases for AMR surveillance. Hear them out on the latest episode of Drug Safety Matters.
The case for vaccine surveillance systems – new podcast episode Ever wondered how safety surveillance differs between vaccines and drugs? Find out in the latest episode of the Drug Safety Matters podcast.
Latest podcast episode – Tailoring drug therapy to your genes Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.
Effectively and ethically communicating risk Informing patients and the public about risks is tricky. UMC's latest podcast digs into the evidence about what works best, and examines the proper role of health communicators.
Medicines safety challenges for refugees – a new Long Read podcast The loss of vital health records is a universal problem for refugees. Our latest Drug Safety Matters Long Read episode explores the issues facing refugees' healthcare providers.
Communicating science through film - new podcast episode Tune in to the latest episode of the Drug Safety Matters podcast for a fascinating discussion of why video is such a powerful tool for science communicators.
Empowering patients as partners – New podcast episode A patient’s perspective can lead to new insights that traditional research may overlook. Yet how may we best harness their perspective to improve patient outcomes?
